No Data
No Data
No Data
No Data
No Data
Presenting on the Emerging Growth Conference 68 Day 1 on March 6 Register Now
Yahoo FinanceMar 5 07:00 ET
Sigyn Therapeutics Announces Reverse Stock Split
SAN DIEGO, CA, Jan. 30, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB:SIGY), a development-stage medical technology company, today announced that a 1-for-40
GlobeNewswireJan 30 08:45 ET
Sigyn Therapeutics Announces Appointment of Jerry DeCiccio as Chief Financial Officer
SAN DIEGO, CA, Dec. 12, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB:SIGY), a development-stage medical technology company, today announced the appointment of
GlobeNewswireDec 12, 2023 08:30 ET
Sigyn Therapeutics Inc GAAP EPS of -$0.02
Seeking AlphaNov 15, 2023 09:55 ET
Sigyn Therapeutics Reports Third Quarter 2023 Financial Results
SAN DIEGO, CA, Nov. 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire –Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB:SIGY), a development-stage medical technology company, today announces financial results for
GlobeNewswireNov 14, 2023 17:11 ET
Sigyn Therapeutics Discloses "DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES" Patent Submission and Related ImmunePrep Trademark Application
SAN DIEGO, CA, May 17, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB:SIGY), a development-stage medical technology company, disclosed today that it has
GlobeNewswireMay 17, 2023 07:00 ET
No Data
No Data